Physician practice facilitation ensures key medical care reaches children

Leona Cuttler, MD, knew in her core that the simple act of adding an outside eye could dramatically improve pediatric care. Today, a study of more than 16,000 patient visits published online in the journal Pediatrics proves Cuttler's thesis correct. The lead investigator on the research project, Cuttler succumbed to cancer late last year. But her colleagues are committed to seeing its lessons disseminated across the country.

"It was an honor to work on this project with Dr. Cuttler," said study first author Sharon B. Meropol, MD, PhD, Assistant Professor, Departments of Pediatrics and Epidemiology and Biostatistics, Case Western Reserve School of Medicine, and , University Hospitals Rainbow Babies & Children's Hospital (UH Rainbow). "This project is one important example of her remarkable legacy as a researcher and child health advocate."

Cuttler, Professor of Pediatrics and Bioethics, Case Western Reserve School of Medicine, and the William T. Dahms Chair in Pediatric Endocrinology, Diabetes, and Metabolism at UH Rainbow, knew all too well children receive, on average, just half the recommended health care they need. Disadvantaged children—often the most at risk for a range of ailments—tend to receive even less. She believed a trained practice facilitator—or coach—could help to make a major, measurable difference in children's treatment.

To test the theory, Cuttler, Meropol and their colleagues engaged with pediatric and family practices across greater Cleveland, including more than a dozen within the University Hospitals health system. Ultimately 30 entities participated in the project, a randomized clinical trial that assessed the impact of "practice-tailored facilitation" on providers' ability to meet quality care standards in three critical areas: obesity detection and counseling, lead exposure screening, and fluoride varnish application to prevent tooth decay. The facilitator, or coach, doesn't tell the provider what to do, but rather collaborates with the entire practice to help its members devise their own solutions.

"Practice-tailored facilitation is gaining traction as a viable practice enhancement for improving child health care delivery," Meropol said. "A practice facilitator, or practice 'coach', collaborates with practices to develop and implement their own changes from within."

The study intentionally delayed intervention for 14 of the practices by four months. Those medical groups served as the "control" sample so researchers could assess more accurately just how much of an impact the coach's presence could make. The answer? Enormous. The practices that received interventions from the outset of the study, for example, improved their ability to meet obesity screening and counseling standards by a factor more than six times greater than those in the control group. And the application of fluoride varnish? More than 20 times greater. The margin for lead screening treatment was closer, but the early intervention group still excelled over those practices that had not yet received the benefit of a coach.

"We had to make the comparison between the active intervention and the non-intervention groups for those first four months," Meropol said. "We needed to show it was the intervention itself that was making the difference rather than something else going on at the same time. Still, we deliberately structured the study so that all practices would receive the benefits of the intervention no later than four months into the trial."

Once practices in the control group actually got to work with the trained coaches, their data improved dramatically as well. After receiving an equivalent amount of practice-tailored facilitation, the delayed-intervention practices reached quality standards at a rate of 87.1 percent in obesity screening, 90.1 percent in lead screening and 89.9 percent in fluoride varnish. Both early and later intervention practices maintained high success rates in all three areas of pediatric prevention care delivery when evaluated two months after the end of the full six-month intervention.

"The physician practices participating in the trial were highly motivated and really poised to improve," she said. "The facilitator just acted as the catalyst for improvement."

To initiate the process, the practice facilitator shared baseline data with each practice. The facilitator then offered resources and led brainstorming sessions with practice members. Through the process of discussion and debate, the group developed its own solutions. As a result, each practice had its own uniquely tailored improvement plan.

"Follow-up was key to our success. Each week, the facilitator visited the practice and either met formally or huddled with them to review successes and decide what changes to implement the coming week," Meropol said. "It's what is known in quality improvement science as 'plan-do-study-act' cycles. You make a plan, carry it out, evaluate it, change the plan as needed and then repeat the cycle."

More information: Practice-Tailored Facilitation to Improve Pediatric Preventive Care Delivery: A Randomized Trial, Meropol, et al. Pediatrics peds.2013-1578. DOI: 10.1542/peds.2013-1578

add to favorites email to friend print save as pdf

Related Stories

Rising role seen for health education specialists

Apr 24, 2014

(HealthDay)—A health education specialist can help family practices implement quality improvement projects with limited additional financial resources, according to an article published in the March/April ...

Supermarket access key ingredient in obesity programs

May 03, 2014

Living close to a supermarket appears to be a key factor in the success of interventions to help obese children eat better and improve their weight, according to a study to be presented Saturday, May 3, at the Pediatric Academic ...

Recommended for you

Virus drugmaker fights pediatricians' new advice

Jul 28, 2014

(AP)—A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the leading U.S. pediatrician's group, which recommends scaling back use of the medicine.

User comments